- (Update) Maximum Drug Retail Price - Information, References, Issuances and IEC Materials
- Standard Information, Education, and Communication (IEC) Materials for the Implementation of Maximum Retail Price (MRP) for Drugs and Medicines
- Labelling Requirements on the Implementation of Executive Order No. 104 dated 17 February 2020 with the subject "Improving Access to Healthcare through the Regulation of Prices in the Retail of Drugs and Medicines"
- Implementation of the Executive Order No. 104 entitled "Improving Access to Healthcare through the Regulation of Prices in the Retail of Drugs and Medicines"
- Postponement of 2020 AMS Training
- Advisory on the submission of comments/suggestions for the AO on Health Technology Assessment
What is Advisory Council?
The Advisory Council is a multi-sectoral body which was created by virtue of Republic Act (RA) No. 9502, otherwise known as the “Universally Accessible Cheaper and Quality Medicines Act of 2008,” to make recommendations to the Secretary of Health on appropriate measures to promote and ensure the access of all Filipinos to affordable quality and essential medicines.
The members of the Council consist of different government agencies, private, non-governmental, patient and professional organizations, development partners, academe, and civil societies which convene quarterly to discuss issues relevant to the implementation of the law and its rules and regulations, such as the intellectual property, drug price monitoring and evaluation, financing, strengthening of the Food and Drug Administration, rational use of medicines, and pharmacy and healthcare professional practices.
What are Functions of the Advisory Council for Price Regulation?
- Gives advice to the Secretary of Health
- Assists the government in the implementation of guidelines as created.
- Promotes transparency in the drug price regulation system process including the system for implementing the Maximum Drug Retail Price Policy (MDRP) and the Government-Mediated Access Price (G-MAP).
The Council has been an arm of the DOH in the implementation of its guidelines. On July 08, 2009, then President Gloria Macapagal-Arroyo, reduce the prices of their medicines. The council made a recommendation to the Secretary of Health by creating agreements through a series of consulation with pharmaceutical companies in line with the implementation of the voluntary reductions. On July 24, 2009 the Advisory Council Resolution 2009-001 entitled Implementing the Voluntary Price Reduction for at/least 16 Molecules and 41 Drug Preparations was approved and signed by former Secretary Francisco T. Duque III, MD. MSc.
What is the Basis for the Creation of the Advisory Council?
Republic Act 9502 or the Universally Accessible Cheaper and Quality Medicines Act of 2008 Chapter 3. Section 18 states that. "Drugs and Medicine Price Monitoring and Regulation Authority of the Secretary of the Department of Health"- To implement the policies of this Act under this Chapter, the Secretary of the Deparment of Health is hereby authorized to establish and initiate a price monitoring and regulation system for drugs and medicines within on one hundred twenty (120) days after the enactment of this Act. The Secretary of the Department of Health may also create such bodies, consultative councils, from which the advice may be sought in the implementation of a drug or medicines price monitoring and regulation policy. Such bodies or consultative Councils created of the Secretary of the Department of Health shall coordinate its effort together with other government agencies.